Immunotherapy for glioma: Current management and future application

Gliomas are intrinsic brain tumors that originate from neuroglial progenitor cells. Conventional therapies, including surgery, chemotherapy, and radiotherapy, have achieved limited improvements in the prognosis of glioma patients. Immunotherapy, a revolution in cancer treatment, has become a promisi...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cancer letters Ročník 476; s. 1 - 12
Hlavní autori:	Xu, Shengchao, Tang, Lu, Li, Xizhe, Fan, Fan, Liu, Zhixiong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Ireland Elsevier B.V 28.04.2020 Elsevier Limited
Predmet:	Antibodies Apoptosis Blood-brain barrier Brain cancer Brain Neoplasms - immunology Brain Neoplasms - pathology Brain Neoplasms - therapy Brain tumors Cancer therapies Central nervous system Checkpoint Chemotherapy Clinical trials Cytotoxicity Disease Management FDA approval Glioma Glioma - immunology Glioma - pathology Glioma - therapy Humans Immunotherapy Immunotherapy - methods Ligands Medical prognosis Medical research Melanoma Oncolytic virus Progenitor cells Prognosis Radiation therapy Stem cells Surgery Tumors Vaccine Vascular endothelial growth factor Checkpoint Vaccine Oncolytic virus Glioma Immunotherapy
ISSN:	0304-3835, 1872-7980, 1872-7980
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!